Ventricular non-compaction review

Shaurya Srivastava1, Majid Yavari2, Abdullah Al-Abcha2

  • 1Department of Internal Medicine, Michigan State University, East Lansing, USA. srivas28@msu.edu.

Insights

Left ventricular non-compaction cardiomyopathy (LVNC) is a rare heart condition. This review covers its causes, diagnosis, and management, highlighting the need for standardized guidelines.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Genetics

Background:

  • Left ventricular non-compaction cardiomyopathy (LVNC) is a rare, unclassified cardiomyopathy.
  • It can lead to heart failure, arrhythmias, and embolic events in adults.
  • Diagnostic criteria across echocardiography, CMR, and CT imaging are not standardized.

Purpose of the Study:

  • To provide a comprehensive review of LVNC.
  • To discuss etiologies, pathogenesis, and diagnostic criteria.
  • To explore current management and treatment strategies, addressing data limitations.

Main Methods:

  • Literature review of existing studies on LVNC.
  • Analysis of diagnostic imaging modalities (echocardiography, CMR, CT).
  • Review of current management practices and treatment debates.

Main Results:

  • LVNC diagnosis lacks standardized criteria, complicating management.
  • The condition presents in various forms, influencing treatment approaches.
  • Evidence for definitive management guidelines regarding anticoagulation and arrhythmia prevention is limited.

Conclusions:

  • LVNC requires further research to establish diagnostic standards.
  • Standardized management guidelines are needed to improve patient outcomes.
  • Comprehensive understanding of LVNC's diverse presentations is crucial for effective treatment.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
134
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
157
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
104
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
95
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
112
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
109